Cited by 1,475Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Health and Risk FactorsCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

Alexander, Charles M., Landsman, Pamela B., Teutsch, Steven M., Haffner, Steven M.·2003·Diabetes

DOI 10.2337/diabetes.52.5.1210

Open this paper in CoChat — free account

Abstract

Although the individual components of the metabolic syndrome are clearly associated with increased risk for coronary heart disease (CHD), we wanted to quantify the increased prevalence of CHD among people with metabolic syndrome. The Third National Health and Nutrition Examination Survey (NHANES III) was used to categorize adults over 50 years of age by presence of metabolic syndrome (National Cholesterol Education Program [NCEP] definition) with or without diabetes. Demographic and risk factor information was determined for each group, as well as the proportion of each group meeting specific criteria for metabolic syndrome. The prevalence of CHD for each group was then determined. Metabolic syndrome is very common, with ∼44% of the U.S. population over 50 years of age meeting the NCEP criteria. In contrast, diabetes without metabolic syndrome is uncommon (13% of those with diabetes). Older Americans over 50 years of age without metabolic syndrome regardless of diabetes status had the lowest CHD prevalence (8.7% without diabetes, 7.5% with diabetes). Compared with those with metabolic syndrome, people with diabetes without metabolic syndrome did not have an increase in CHD prevalence. Those with metabolic syndrome without diabetes had higher CHD prevalence (13.9%), and those with both metabolic syndrome and diabetes had the highest prevalence of CHD (19.2%) compared with those with neither. Metabolic syndrome was a significant univariate predictor of prevalent CHD (OR 2.07, 95% CI 1.66–2.59). However, blood pressure, HDL cholesterol, and diabetes, but not presence of metabolic syndrome, were significant multivariate predictors of prevalent CHD. The prevalence of CHD markedly increased with the presence of metabolic syndrome. Among people with diabetes, the prevalence of metabolic syndrome was very high, and those with diabetes and metabolic syndrome had the highest prevalence of CHD. Among all individuals with diabetes, prevalence of CHD was increased compared with those with metabolic syndrome without diabetes. However, individuals with diabetes without metabolic syndrome had no greater prevalence of CHD compared with those with neither.

Integrity signals

Registry

Crossref · 10.2337/diabetes.52.5.1210

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Prevalence of the Metabolic Syndrome Among US Adults: Findings From the Third National Health and Nutrition Examination Survey
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Cardiovascular Survey Methods.
Rose, G., & Blackburn, H. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,090

Show all 30 references

Sorted by citations

Items 601–700 of 998

The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia
Graziano, E., Peghin, M., Martino, M. D., Carlo, C. D., Porto, A. D., Bulfone, L., Casarsa, V., Sozio, E., Fabris, M., Cifù, A., et al. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.07.003 · Cited by 24
A Novel Model for Metabolic Syndrome Risk Quantification Based on Areal Similarity Degree
Jeong, S., Jo, Y. M., Shim, S., Choi, Y.-J., & Youn, C. (2013) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2013.2286197 · Cited by 24
“In addition to hyperglycemia, low high-density lipoprotein (HDL) cholesterol and hypertension usually indicate a significantly greater risk compared with the presence of obesity or high triglycerides [14], [15].”
Background
Use of the metabolic syndrome in pediatrics: a blessing and a curse
Battista, M., Murray, R. D., & Daniels, S. R. (2009) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2009.04.003 · Cited by 24
“For xample, having metabolic syndrome imparts a twofold reater risk of incident cardiovascular disease mortality ver those without the syndrome.(1,14,15) Furthermore, as emonstrated by the Framingham Offspring and San Antoio Heart Study, the predicted risk for coronary heart disase in individuals with metabolic syndro…”
Background
Sex Factors in the Metabolic Syndrome as a Predictor of Cardiovascular Disease
Suh, S., Baek, J.-H., Bae, J. C., Kim, K.-N., Park, M. K., Kim, D. K., Cho, N. H., & Lee, M. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.4.522 · Cited by 24
PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample*
Wolf, A. M., Finer, N., Allshouse, A. A., Pendergast, K., Sherrill, B. H., Caterson, I. D., Hill, J. O., Aronne, L. J., Hauner, H., Radigue, C., et al. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00895.x · Cited by 24
Quantifying Cardiovascular Risks in Patients With Metabolic Syndrome Undergoing Total Joint Arthroplasty
Gandhi, K., Viscusi, E. R., Schwenk, E. S., Pulido, L. F., & Parvizi, J. (2011) · The Journal of Arthroplasty · doi:10.1016/j.arth.2011.06.027 · Cited by 24
Impact of metabolic syndrome on mortality and morbidity after coronary artery bypass grafting surgery
Faritus, Z., Ardeshiri, M., Haghighi, Z., Bakhshandeh, H., Kargar, F., & Aghili, R. (2014) · Research in Cardiovascular Medicine · doi:10.5812/cardiovascmed.20270 · Cited by 24
Circulatory Syndrome: An Evolution of the Metabolic Syndrome Concept!
Khoshdel, A., Carney, S. L., & Gillies, A. H. B. (2012) · Current Cardiology Reviews · doi:10.2174/157340312801215773 · Cited by 24
“Several epidemiologic studies have illustrated the relationship between the metabolic syndrome, cardiovascular events and mortality [9-16]; however the syndrome was criticised by the American Diabetes Association a few years ago for its modest consistency and limited clinical application [11] and the use of the term m…”
Background
State of the heart in the metabolic syndrome
SIMONE, G. D. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.06.006 · Cited by 24
The “New Deadly Quartet” for Cardiovascular Disease in the 21st Century: Obesity, Metabolic Syndrome, Inflammation and Climate Change: How Does Statin Therapy Fit into this Equation?
Clearfield, M. B., Pearce, M., Nibbe, Y., Crotty, D. A., & Wagner, A. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0380-2 · Cited by 23
Exercise, Insulin Resistance, and Hypertension: A Complex Relationship
Brock, C. M., King, D. S., Wofford, M. R., & Harrell, T. K. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.60 · Cited by 24
“The guidelines suggest that a 10-kg 10-kg weight loss (22 lb) will provide a reduction in systolic blood pressure of 5–20 mm Hg. Regular physical activity such as brisk 32,33 Physical activity can provide a reduction in systolic blood pressure of up to 9 mm Hg.”
Diabetes in the Hispanic population
Idrogo, M., & Mazze, R. (2004) · Postgraduate Medicine · doi:10.3810/pgm.2004.12.1622 · Cited by 24
A Study of Carotid Atherosclerosis in Patients with Non-alcoholic Fatty Liver Disease
Mishra, S., Yadav, D., Gupta, M., Mishra, H. K., & Sharma, P. (2012) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-012-0286-8 · Cited by 23
RBANS Norms based on the Relationship of Age, Gender, Education, and WRAT-3 Reading to Performance within an Older African American Sample
Andreotti, C., & Hawkins, K. A. (2015) · The Clinical Neuropsychologist · doi:10.1080/13854046.2015.1039589 · Cited by 23
High levels of saturated very long-chain fatty acid (hexacosanoic acid; C26:0) in whole blood are associated with metabolic syndrome in Japanese men
Kume, A., Miyazaki, T., Kitamura, Y., Oshida, K., Yanagisawab, N., Takizawa, H., Fujii, K., Kiyanagi, T., Sumiyoshi, K., Ohmura, H., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.12.014 · Cited by 23
Alloxan-induced diabetes exacerbates coronary atherosclerosis and calcification in Ossabaw miniature swine with metabolic syndrome
Badin, J. K., Kole, A., Stivers, B., Progar, V., Pareddy, A. R., Alloosh, M., & Sturek, M. S. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1431-9 · Cited by 24
Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome
Bianchi, C., Penno, G., Malloggi, L., Barontini, R., Corfini, M., Giovannitti, M. G., Cianni, G. D., Prato, S. D., & Miccoli, R. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2006.07.007 · Cited by 23
Genetic determinants of the metabolic syndrome
Sale, M. M., Woods, J., & Freedman, B. I. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0036-5 · Cited by 23
“The metabolic syndrome has been associated with an increased risk for the subsequent development of type 2 diabetes, cardiovascular disease [ 4 ], and higher cardiovascular and all-cause mortality [5].”
Background
Review: Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection
Whaley‐Connell, A. T., Pavey, B. S., Chaudhary, K. R., Saab, G., & Sowers, J. R. (2007) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944707082697 · Cited by 22
Left ventricular hypertrophy in normoalbuminuric type 2 diabetic patients not taking antihypertensive treatment
Sato, A., Tarnow, L., Nielsen, F. S., Knudsen, E. C., & Parving, H. (2005) · QJM · doi:10.1093/qjmed/hci137 · Cited by 23
“7% of the attributable risk for coronary heart disease in a US population aged 50 years.(3) Starting as an adaptation, left ventricular hypertrophy can itself contribute to increased rates of cardiovascular events, through its effects on ventricular function, coronary circulation, and arrhythmogenesis.”
Background
The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease
Lee, W.-L., Lee, W., Chen, Y., Liu, T.-J., Liang, K., Ting, C.-T., & Sheu, W. H. (2006) · Metabolism · doi:10.1016/j.metabol.2006.03.013 · Cited by 23
“The prevalence of metabolic syndrome is about 5% to 40% [14,26,27].”
Background
Impact of optimal glycemic control on the progression of coronary artery calcification in asymptomatic patients with diabetes
Won, K., Han, D., Lee, J. H., Lee, S., Sung, J. M., Choi, S., Chun, E. J., Park, S. H., Han, H., Sung, J., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.03.112 · Cited by 23
Haplotype combination of Calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes
Kang, E. S., Nam, M., Kim, H. J., Kim, H. J., Myoung, S. M., Rhee, Y., Ahn, C. W., Soo, B., & Lee, H. C. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.01.011 · Cited by 23
Das metabolisches Syndrom – ein umstrittenes diagnostisches Konzept
Moebus, S., & Stang, A. (2007) · Herz · doi:10.1007/s00059-007-3025-9 · Cited by 25
Differences in coronary heart disease prevalence and risk factors in African and White patients with type 2 diabetes.
Kalk, W., & Joffe, B. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.10.014 · Cited by 27
The Metabolic Syndrome (Emperor) Wears No Clothes
Oda, E. (2006) · Diabetes Care · doi:10.2337/dc06-1453 · Cited by 23
“Neither abdominal obesity nor metabolic syndrome, as defined by the National Cholesterol Education Program Adult Treatment Panel III criteria, were a significant independent risk factor for CVD in multiple regression analyses (6,7), while very low levels of CRP were useful for risk prediction among women with calculat…”
Plasminogen activator inhibitor-1 mediate downregulation of adiponectin in type 2 diabetes patients with metabolic syndrome
Nawaz, S. S., & Siddiqui, K. (2022) · Cytokine X · doi:10.1016/j.cytox.2022.100064 · Cited by 22
Association of insulin resistance and coronary artery remodeling: an intravascular ultrasound study
Kim, S., Moon, J.-Y., Lim, Y. M., Kim, K. H., Yang, W., Sung, J., Yoo, S. M., Kim, I. J., Lim, S., Cha, D., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0238-8 · Cited by 22
Evaluation of vitamin B-12 level in middle-aged obese women with metabolic and non-metabolic syndrome: case-control study
Baltacı, D., Kutlucan, A., Öztürk, S., Karabulut, İ., Yıldırım, H. A., Çeler, A., Celbek, G., & Kara, İ. H. (2012) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1105-6 · Cited by 22
Increased concentration of plasminogen activator inhibitor-1 and fibrinogen in individuals with metabolic syndrome
Palomo, I. F. (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000092 · Cited by 22
Metabolic syndrome prevalence and characteristics in Greek adults with familial combined hyperlipidemia
Skoumas, J., Papadimitriou, L., Pitsavos, C. E., Masoura, C., Giotsas, N., Chrysohoou, C. A., Toutouza, M. G., Panagiotakos, D. B., & Stefanadis, C. (2006) · Metabolism · doi:10.1016/j.metabol.2006.09.007 · Cited by 23
Insulin sensitivity: Gender-related differences in subjects with normal glucose tolerance
Schianca, G. P. C., Castello, L. M., Rapetti, R., Limoncini, A., & Bartoli, E. (2005) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.05.004 · Cited by 22
The effect of physical exercise and caloric restriction on the components of metabolic syndrome
Torres‐Leal, F. L., de Capitani, M. D., & Tirapegui, J. (2009) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502009000300003 · Cited by 24
“…the deleterious effects related to this syndrome as well as to reduce several atherosclerotic risk factors that may affect this same individual (Alexander et al., 2003; Solymoss et al., 2003; Girman et al., 2004; Malik et al., 2004; Ninomiya et al., 2004; Olijhoek et al., 2004; Mcneill et al.,…”
Background
Positive effects of egg-derived phospholipids in patients with metabolic syndrome
Skórkowska‐Telichowska, K., Kosińska, J., Chwojnicka, M., Tuchendler, D., Tabin, M., Tuchendler, R., Bobak, Ł., Trziszka, T., & Szuba, A. (2016) · Advances in Medical Sciences · doi:10.1016/j.advms.2015.12.003 · Cited by 22
Alanine Aminotransferase Is Associated With Metabolic Syndrome Independently of Insulin Resistance
Yun, J. E., Kim, S. Y., Kang, H., Lee, S. J., Kimm, H., & Jee, S. H. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-0465 · Cited by 22
Sociodemographic risk factors of metabolic syndrome in middle-aged women: results from a population-based study of Swedish women, The Women's Health in the Lund Area (WHILA) Study
Qader, S. S., Shakir, Y. A., Nyberg, P., & Samsioe, G. (2008) · Climacteric · doi:10.1080/13697130802451787 · Cited by 22
The metabolic syndrome ? a growing problem
Tonkin, A. (2004) · European Heart Journal Supplements · doi:10.1016/j.ehjsup.2004.01.009 · Cited by 22
Diabetes and the metabolic syndrome—When is it best to intervene to prevent?
Haffner, S. M. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.01.002 · Cited by 22
Self-citation
Metabolic Syndrome in Thyroid Disease
Iwen, K. A., Oelkrug, R., Kalscheuer, H., & Brabant, G. E. (2018) · Frontiers of hormone research · doi:10.1159/000485996 · Cited by 21
Association between Alcohol Drinking and Metabolic Syndrome in Japanese Male Workers with Diabetes Mellitus
Wakabayashi, I. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7435 · Cited by 21
Factors Associated with Coronary Artery Disease in Young Population (Age⩽40): Analysis with 217 Cases
Yang, W., Yang, Z. K., Wu, Y., Qiao, S.-B., Yang, Y., & Chen, J. (2014) · Chinese Medical Sciences Journal · doi:10.1016/s1001-9294(14)60022-5 · Cited by 21
Baseline forced expiratory volume in the first second as an independent predictor of development of the metabolic syndrome
Hsiao, F., Wu, C., Su, S., Sun, M.-T., Hsieh, C., Hung, Y.-J., He, C., & Pei, D. (2009) · Metabolism · doi:10.1016/j.metabol.2009.10.001 · Cited by 21
“The metabolic syndrome (MetS), comprising insulin resistance, central obesity, dyslipidemia, and hypertension, is associated with the development of type 2 diabetes mellitus and increased cardiovascular mortality [1-4].”
Background
Obesity: the modern approach to the problem
Razina, A. O., Achkasov, E. E., & Runenko, S. D. (2015) · Obesity and metabolism · doi:10.14341/omet201613-8 · Cited by 21
Augmented oxidative stress and preserved vasoconstriction induced by hydrogen peroxide in coronary arteries in obesity: role of COX‐2
Santiago, E., Martínez, M. P., Climent, B., Muñoz, M., Briones, A. M., Salaíces, M., García‐Sacristán, A., Rivera, L., & Prieto, D. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13579 · Cited by 21
“Obesity and metabolic syndrome greatly enhance the risk of heart disease and heart failure (Alexander et al., 2003).”
Background
The Association between Mineral and Trace Element Concentrations in Hair and the 10-Year Risk of Atherosclerotic Cardiovascular Disease in Healthy Community-Dwelling Elderly Individuals
Choi, H.-I., Ko, H., Kim, A., & Moon, H. (2019) · Nutrients · doi:10.3390/nu11030637 · Cited by 21
“The prevalence of coronary heart disease was markedly higher in subjects with than without metabolic syndrome [38,39], with the individual components of the metabolic syndrome also associated with an increased risk of coronary heart disease.”
Background
Menopausal symptoms and the metabolic syndrome in Nigerian women with type 2 diabetes mellitus
Ogbera, A. O., Fasanmade, O. A., & Kalra, S. (2010) · Climacteric · doi:10.3109/13697130903568526 · Cited by 20
The significance of carotid artery atheromas on panoramic radiographs in the diagnosis of occult metabolic syndrome
Friedlander, A. H., & Golub, M. S. (2005) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2005.04.027 · Cited by 22
Implementation of Guidelines for the Management of Arterial Hypertension. The Impulsion Study
Karagiannis, A. I., Hatzitolios, A. I., Athyros, V. G., Deligianni, K., Charalambous, C., Papathanakis, C., Theodosiou, G., Drakidis, T., Chatzikaloudi, V., Kamilali, C., et al. (2009) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192400903010026 · Cited by 21
Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients
Vlek, A. L. M., van der Graaf, Y., Spiering, W., Visseren, F. L. J., & SMART study group (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.5 · Cited by 21
“However, in multivariate analysis metabolic syndrome was no longer a significant predictor of cardiovascular disease”
Background
Metabolic syndrome and the older male population
Mazza, A. D., & Morley, J. E. (2007) · The Aging Male · doi:10.1080/13685530701249592 · Cited by 20
Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls
Gullaksen, S., Funck, K. L., Laugesen, E., Hansen, T. K., Dey, D., & Poulsen, P. L. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119825761 · Cited by 19
Are maternal metabolic syndrome and lipid profile associated with preterm delivery and preterm premature rupture of membranes?
niyati, S., Moghaddam‐Banaem, L., Sourinejad, H., & Mokhlesi, S. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05738-5 · Cited by 20
Metabolic syndrome is a predictor for an ECG sign of no-reflow after primary PCI in patients with acute ST-elevation myocardial infarction
Tartan, Z., Özer, N., Uyarel, H., Akgül, Ö., Gül, M., Çetın, M., Kaşıkçıoğlu, H., & Çam, N. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.02.015 · Cited by 20
Is there any relation between insulin resistance and cognitive function in the elderly?
Işık, A. T., Cankurtaran, M., Bozoğlu, E., Cömert, B., Doruk, H., & Mas, M. R. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207005406 · Cited by 20
“For the metabolic syndrome diagnosis, the National Cholesterol Education Program (NCEP) (Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults) was used (Alexander et al., 2003).”
Method
A comparison of the assessment and management of cardiometabolic risk in patients with and without type 2 diabetes mellitus in Canadian primary care
Teoh, H., Després, J., Dufour, R., FITCHETT, D. H., Goldin, L., Goodman, S. G., Harris, S. B., Langer, A., Lau, D. C. W., Lonn, E., et al. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12134 · Cited by 21
“individuals with type 2 diabetes mellitus (T2DM) are at risk for metabolic and cardiovascular co-morbidities that relate to their elevated cardiometabolic risk (CMR), a concept that highlights the importance to consider all key risk factors that contribute to the absolute risk of developing cardiovascular disease (CVD…”
Background
The Cardiometabolic Syndrome and Cardiovascular Disease
Ash‐Bernal, R., & Peterson, L. R. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.0197-3118.2006.05452.x · Cited by 21
Associations between Metabolic Syndrome and Inadequate Sleep Duration and Skipping Breakfast
Kim, N., Shin, D. H., Kim, H.-T., Jeong, S. M., Kim, S.-Y., & Son, K. Y. (2015) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2015.36.6.273 · Cited by 20
Comparing serum concentration of spexin among patients with metabolic syndrome, healthy overweight/obese, and normal-weight individuals.
Bitarafan, V., Esteghamati, A., Azam, K., Yosaee, S., & Djafarian, K. (2019) · Europe PMC (PubMed Central) · doi:10.34171/mjiri.33.93 · Cited by 20
Metabolic Syndrome: Historical Perspectives
Leslie, B. R. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00002 · Cited by 20
How to survive diabetes
Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1275-1 · Cited by 20
“Diabetes alone was not a risk factor for coronary heart disease in this study [31].”
Background
Endothelial progenitor cells and their potential clinical implication in cardiovascular disorders
Zeoli, A., Dentelli, P., & Brizzi, M. F. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345729 · Cited by 20
Salivary S100 proteins screen periodontitis among Korean adults
Karna, S., Shin, Y., Kim, S., & Kim, H. (2018) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13059 · Cited by 20
“NCEP- defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older.”
Method
Thiazolidinediones
Reynolds, K., & Goldberg, R. B. (2006) · Treatments in Endocrinology · doi:10.2165/00024677-200605010-00004 · Cited by 20
Suppressive Effects of Valsartan on Microalbuminuria and CRP in Patients with Metabolic Syndrome (Val-Mets)
Shishido, T., Konta, T., Nishiyama, S., Miyashita, T., Miyamoto, T., Takasaki, S., Nitobe, J., Watanabe, T., Takeishi, Y., & Kubota, I. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.531837 · Cited by 19
Preventing Vascular Effects on Brain Injury and Cognition Late in Life: Knowns and Unknowns
Carmichael, O. T. (2014) · Neuropsychology Review · doi:10.1007/s11065-014-9264-7 · Cited by 19
“Besides being major risk factors for heart disease, stroke, and early mortality (Alexander et al. 2003; Chobanian et al. 2003), each of these risk factors is associated with decline in cognitive abilities late in life, including clinical dementia syndromes (Debette et al. 2011; Joas et al. 2012;…”
Vitiligo: The Association With Metabolic Syndrome and the Role of Simvastatin as an Immunomodulator
Verma, D., Hussain, K., Namiq, K. S., Firoz, A., Bouchama, M., Raza, M., Haris, M., & Khan, S. (2021) · Cureus · doi:10.7759/cureus.14029 · Cited by 19
Temporal physical activity patterns are associated with obesity in U.S. adults
Aqeel, M. M., Guo, J., Lin, L., Gelfand, S. B., Delp, E. J., Bhadra, A., Richards, E. A., Hennessy, E., & Eicher‐Miller, H. A. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106538 · Cited by 20
The High Molecular Weight Adiponectin Level is Associated with the Atherogenic Lipoprotein Profiles in Healthy Japanese Males
Miyazaki, T., Hiki, M., Shimada, K., Kume, A., Kiyanagi, T., Sumiyoshi, K., Ohmura, H., & Daida, H. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.22152 · Cited by 19
Prevalence of the Metabolic Syndrome in Type 2 Diabetic Patients
Kim, T. H., Kim, D. J., Lim, S. K., Jeong, I., Son, H. S., Chung, C. H., Koh, G., Lee, D. H., Won, K. C., Park, J. H., et al. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.1.40 · Cited by 19
Status and determinants of individual actions to reduce health impacts of air pollution in US adults
Lissåker, C., Talbott, E. O., Kan, H., & Xu, X. (2014) · Archives of Environmental & Occupational Health · doi:10.1080/19338244.2014.988673 · Cited by 19
Epigenetic Manifestation of Metabolic Syndrome and Dietary Management
Chaudhary, N., Nakka, K. K., Maulik, N., & Chattopadhyay, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4387 · Cited by 19
Metabolic syndrome in the rural population of Wardha, Central India: An exploratory factor analysis
Deshmukh, P. R., Kamble, P. D., Goswami, K., & Garg, N. (2013) · Indian Journal of Community Medicine · doi:10.4103/0970-0218.106625 · Cited by 19
Depression is Associated with Increased Risk for Metabolic Syndrome in Latinos with Type 2 Diabetes
Cárdenas, V., Mausbach, B. T., Sommerfeld, D. H., Jimenez, D. E., von Känel, R., Ho, J. S., Garcia, P., & Aarons, G. A. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.02.017 · Cited by 21
“The presence of diabetes is a known risk factor for CVD, particularly heart disease and stroke.”
BackgroundResultInfluential
The dynamic behaviour of metabolic syndrome and its components in an eight-year population-based cohort from the Mediterranean
Barceló, M. A., Rodríguez‐Poncelas, A., Sáez, M., & de Tuero, G. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176665 · Cited by 19
Metabolic syndrome in north Indian type 2 diabetes mellitus patients: A comparison of four different diagnostic criteria of metabolic syndrome
Gahlan, D., Rajput, R., & Singh, V. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.10.011 · Cited by 19
Pathophysiologic, Diagnostic, and Therapeutic Aspects of the Metabolic Syndrome
Giles, T. D., & Sander, G. E. (2005) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2005.04763.x · Cited by 19
The Metabolic Syndrome and Cardiometabolic Risk: Scope of the Problem and Current Standard of Care
Lender, D., & Clough, S. S. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.5part2.3s · Cited by 19
Effects of the Cannabinoid-1 Receptor Blocker Rimonabant on Weight Reduction and Cardiovascular Risk Factors in Overweight Patients: 1-Year Experience From the RIO-Europe Study
Gaal, L. F. V., Rissanen, A., Scheen, A. J., Ziegler, O., & Rössner, S. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.06.021 · Cited by 19
Neither the presence of metabolic syndrome as defined by the IDF guideline nor an increased waist circumference increased the risk of microvascular or macrovascular complications in Japanese patients with type 2 diabetes
Iwasaki, T., Togashi, Y., Ohshige, K., Yoneda, M., Fujita, K., Nakajima, A., & Terauchi, Y. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.035 · Cited by 20
Association of the Metabolic Syndrome With Early Coronary Disease in Families With Frequent Myocardial Infarction
Reinhard, W., Holmer, S. R., Fischer, M., Gloeckner, C. J., Hubauer, U., Baessler, A., Mayer, B., Schunkert, H., Riegger, G. A. J., & Hengstenberg, C. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.10.063 · Cited by 19
Impact of Blood Pressure and Other Components of the Metabolic Syndrome on the Development of Cardiovascular Disease
Kang, G., Guo, L., Guo, Z., Hu, X., Wu, M., Zhou, Z., Zhou, H., Liu, S., & Chen, F. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0422 · Cited by 18
Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality
Honarvar, M., Mehran, L., Masoumi, S., Agahi, S., Khalili, S., Azizi, F., & Amouzegar, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-41546-y · Cited by 18
How Much Information Can Metabolic Syndrome Provide?
Beckstead, J., & Beckie, T. M. (2011) · Medical decision making · doi:10.1177/0272989x10373401 · Cited by 22
The relative value of metabolic syndrome and cardiovascular risk score estimates in premature acute coronary syndromes
Kalantzi, K. J., Korantzopoulos, P. G., Tzimas, P. G., Katsouras, C. S., Goudevenos, J. A., & Milionis, H. J. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.10.038 · Cited by 18
Comprehensive Biomarker Testing of Glycemia, Insulin Resistance, and Beta Cell Function Has Greater Sensitivity to Detect Diabetes Risk Than Fasting Glucose and HbA1c and Is Associated with Improved Glycemic Control in Clinical Practice
Varvel, S. A., Vörös, S., Thiselton, D. L., Pottala, J. V., Dall, T., Warnick, G. R., McConnell, J. P., Ghaedi, L., Sasinowski, M., & Graham, T. E. (2014) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-014-9577-1 · Cited by 18
Metabolic Syndrome among Undergraduate Students Attending Medical Clinics for Obligatory Medical Screening
Am, A., Elabid, B., Elhassan, K., & Waggiallah, H. A. (2015) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v14i2.18 · Cited by 18
The Metabolic Syndrome in Older Persons
Sinclair, A. J., & Viljoen, A. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.02.011 · Cited by 18
Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
Kosasih, S., Qin, W. Z., Rani, R. A., Hamid, N. A., Ngiu, C. S., Shah, S. A., Yaakob, Y., & Ali, R. A. R. (2018) · International Journal of Hepatology · doi:10.1155/2018/9252536 · Cited by 18
Hyperglycemia, Hypertension, and Dyslipidemia in Type 2 Diabetes Mellitus: Goals for Diabetes Management
LeRoith, D. (2008) · Clinical cornerstone · doi:10.1016/s1098-3597(09)60021-1 · Cited by 18
Metabolic syndrome and cardiometabolic risk: An update
Grassi, G. M., Seravalle, G., Quarti‐Trevano, F., Dell'ro, R., Bombelli, M., & Mancia, G. (2009) · Blood Pressure · doi:10.1080/08037050802677695 · Cited by 18
Economic Burden of the Components of the Metabolic Syndrome
Marangos, P. J., Okamoto, L. J., & Jaime, J. (2009) · Springer eBooks · doi:10.1007/978-0-387-78665-0_64 · Cited by 19
Psychology and Diabetes Care
Barnard, K. D., & Lloyd, C. E. (2012) · Springer eBooks · doi:10.1007/978-0-85729-573-6 · Cited by 34
Hypertension in people with diabetes and the metabolic syndrome: Pathophysiologic insights and therapeutic update
Ganne, S., Arora, S., Dotsenko, O., McFarlane, S. I., & Whaley‐Connell, A. T. (2007) · Current Diabetes Reports · doi:10.1007/s11892-007-0033-3 · Cited by 18
“Using NHANES data in individuals aged 50 years, 17% of the population have T2DM and 85% of those with T2DM have the MS [ 36 ].”
Method
Factors predicting the development of metabolic syndrome and type II diabetes against a background of hypertension
Lim, H. S., Lip, G. Y. H., Beevers, D. G., & Blann, A. D. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01495.x · Cited by 18
Is Waist Circumference an Essential Component of the Metabolic Syndrome?
Lorenzo, C., Serrano‐Ríos, M., Martínez-Larrad, M. T., González‐Villalpando, C., González‐Sánchez, J. L., Martínez-Calatrava, M. J., Gabriel, R., & Haffner, S. M. (2007) · Diabetes Care · doi:10.2337/dc06-2627 · Cited by 18
Self-citation
The neighbourhood environment and profiles of the metabolic syndrome
Barnett, A. H., Martino, E., Knibbs, L. D., Shaw, J. E., Dunstan, D. W., Magliano, D. J., Donaire-González, D., & Cerin, E. (2022) · Environmental Health · doi:10.1186/s12940-022-00894-4 · Cited by 19
“MetS prevalence increases with age [2] and has been associated with increased risk of coronary heart disease, stroke, diabetes and cancer [2, 3].”
Background
Visceral adiposity and cardiometabolic risks: epidemic of abdominal obesity in North America
Wimalawansa, S. J. (2013) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s32041 · Cited by 17
Here we go again … The metabolic syndrome revisited!
Sadikot, S. S., & Hermans, M. P. (2010) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2010.05.011 · Cited by 18
High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects
Lee, I., Wang, C., Huang, C., Fu, C.-C., & Sheu, W. H. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.11.004 · Cited by 17
Physical activity and health: Metabolic and cardiovascular issues
VUORI, I. M. (2007) · Advances in Physiotherapy · doi:10.1080/14038190701395887 · Cited by 17

Authors: Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M.
Affiliations: Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
The University of Texas at San Antonio Health Science Center (US)
ORCID: Alexander, Charles M.
Teutsch, Steven M.
Venue: Diabetes
Publisher: American Diabetes Association
Published: 2003-05-01
Volume: 52
Issue: 5
Pages: 1210-1214
ISSN: 0012-1797 (ISSN-L)
1939-327X
DOI: 10.2337/diabetes.52.5.1210
OpenAlex: W2151152924
Cited by: 1,475
References: 30
Citations by year: 2026: 9 · 2025: 14 · 2024: 18 · 2023: 20 · 2022: 30 · 2021: 37 · 2020: 32 · 2019: 30 · 2018: 42 · 2017: 39 · 2016: 51 · 2015: 43 · 2014: 61 · 2013: 65 · 2012: 73
FWCI: 77.32
Type: journal article
Language: en
Open access: closed
Locations: Diabetes (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: metabolic syndrome, coronary artery disease, prevalence, older adults, NCEP criteria, NHANES III, cardiovascular risk factors, blood pressure, HDL cholesterol
MeSH terms: Age Factors, Blood Pressure, Body Constitution, Coronary Disease, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Patient Education as Topic, Physical Examination, Surveys and Questionnaires, Risk Factors, Smoking, United States, Prevalence, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks